{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T07:39:06Z","timestamp":1793605146395,"version":"4.5.0"},"reference-count":30,"publisher":"Tech Science Press","issue":"4","license":[{"start":{"date-parts":[[2025,3,23]],"date-time":"2025-03-23T00:00:00Z","timestamp":1742688000000},"content-version":"vor","delay-in-days":81,"URL":"https:\/\/doi.org\/10.32604\/TSP-CROSSMARKPOLICY"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["OR"],"published-print":{"date-parts":[[2025]]},"DOI":"10.32604\/or.2024.057065","type":"journal-article","created":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T04:24:35Z","timestamp":1734582275000},"page":"965-974","update-policy":"https:\/\/doi.org\/10.32604\/tsp-crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Comparison of pegaspargase with concurrent radiation <i>vs<\/i>. P-GEMOX with sequential radiation in early-stage NK\/T-cell lymphoma"],"prefix":"10.32604","volume":"33","author":[{"given":"DEMEI","family":"FENG","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SHENRUI","family":"BAI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GUANJUN","family":"CHEN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"BIBO","family":"FU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CAILU","family":"SONG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HAILIN","family":"TANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LIANG","family":"WANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HUA","family":"WANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"17807","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1038\/s41375-021-01313-2","article-title":"NK-\/T-cell lymphomas","volume":"35","author":"Wang","year":"2021","journal-title":"Leukemia"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.ccell.2020.02.005","article-title":"Genomic and transcriptomic characterization of natural killer T Cell lymphoma","volume":"37","author":"Xiong","year":"2020","journal-title":"Cancer Cell"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s13045-018-0678-1","article-title":"Advances in multiple omics of natural-killer\/T cell lymphoma","volume":"11","author":"Xiong","year":"2018","journal-title":"J Hematol Oncol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"e284","DOI":"10.1016\/S2352-3026(19)30283-2","article-title":"Survival outcomes of patients with extranodal natural-killer T-cell lymphoma: a prospective cohort study from the international T-cell Project","volume":"7","author":"Fox","year":"2020","journal-title":"Lancet Haematol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1088685","DOI":"10.3389\/fimmu.2023.1088685","article-title":"Treatment of extranodal NK\/T-cell lymphoma: from past to future","volume":"14","author":"Yan","year":"2023","journal-title":"Front Immunol"},{"key":"ref6","first-page":"100426","article-title":"Etoposide, dexamethasone, and pegaspargase with sandwiched radiotherapy in early-stage natural killer\/T-cell lymphoma: a randomized phase III study","volume":"4","author":"Zhong","year":"2023","journal-title":"Innovation"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1182\/blood-2017-12-791418","article-title":"Advances in the treatment of extranodal NK\/T-cell lymphoma, nasal type","volume":"131","author":"Yamaguchi","year":"2018","journal-title":"Blood"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"5223","DOI":"10.1158\/1078-0432.CCR-16-0153","article-title":"DDGP versus SMILE in newly diagnosed advanced natural killer\/T-cell lymphoma: a randomized controlled, multicenter, open-label study in China","volume":"22","author":"Li","year":"2016","journal-title":"Clin Cancer Res"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1172307","DOI":"10.3389\/fimmu.2023.1172307","article-title":"Case report: immune modulation after PD-1 inhibitor therapy in a patient with extranodal NK\/T-cell lymphoma secondary to chronic active Epstein-Barr virus disease unveiled by single-cell transcriptomics","volume":"14","author":"Wang","year":"2023","journal-title":"Front Immunol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s13045-022-01293-5","article-title":"How we treat NK\/T-cell lymphomas","volume":"15","author":"Tse","year":"2022","journal-title":"J Hematol Oncol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1002\/ajh.26335","article-title":"Sequential P-GEMOX and radiotherapy for early-stage extranodal natural killer\/T-cell lymphoma: a multicenter study","volume":"96","author":"Zhang","year":"2021","journal-title":"Am J Hematol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"108192","DOI":"10.1016\/j.isci.2023.108192","article-title":"Advances and challenges of immunotherapies in NK\/T cell lymphomas","volume":"26","author":"He","year":"2023","journal-title":"iScience"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"e190194","DOI":"10.1001\/jamanetworkopen.2019.0194","article-title":"Risk-dependent conditional survival and failure hazard after radiotherapy for early-stage extranodal natural killer\/T-cell lymphoma","volume":"2","author":"Liu","year":"2019","journal-title":"JAMA Netw Open"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"e1725","DOI":"10.1634\/theoncologist.2020-0144","article-title":"Pegaspargase combined with concurrent radiotherapy for early-stage extranodal natural killer\/T-cell lymphoma, nasal type: a two-center phase II study","volume":"25","author":"Wang","year":"2020","journal-title":"Oncologist"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1001\/jama.2015.13480","article-title":"The propensity score","volume":"314","author":"Haukoos","year":"2015","journal-title":"JAMA"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1016\/j.jtho.2020.11.030","article-title":"Using propensity score matching to balance the baseline characteristics","volume":"16","author":"Liang","year":"2021","journal-title":"J Thorac Oncol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","article-title":"Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification","volume":"32","author":"Cheson","year":"2014","journal-title":"J Clin Oncol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1182\/bloodadvances.2018021311","article-title":"Risk-adapted survival benefit of IMRT in early-stage NKTCL: a multicenter study from the China lymphoma collaborative group","volume":"2","author":"Wu","year":"2018","journal-title":"Blood Adv"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s13045-017-0452-9","article-title":"The diagnosis and management of NK\/T-cell lymphomas","volume":"10","author":"Tse","year":"2017","journal-title":"J Hematol Oncol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.radonc.2018.04.026","article-title":"Radiotherapy is essential after complete response to asparaginase-containing chemotherapy in early-stage extranodal nasal-type NK\/T-cell lymphoma: a multicenter study from the China lymphoma collaborative group (CLCG)","volume":"129","author":"Deng","year":"2018","journal-title":"Radiother Oncol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41392-020-00331-3","article-title":"Combination of anti-PD-1 antibody with P-GEMOX as a potentially effective immunochemotherapy for advanced natural killer\/T cell lymphoma","volume":"5","author":"Cai","year":"2020","journal-title":"Signal Transduct Target Therapy"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.autrev.2015.02.006","article-title":"P-glycoprotein in autoimmune rheumatic diseases","volume":"14","author":"Garc\u00eda-Carrasco","year":"2015","journal-title":"Autoimmun Rev"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/med.21739","article-title":"Chemical molecular-based approach to overcome multidrug resistance in cancer by targeting P-glycoprotein (P-gp)","volume":"41","author":"Zhang","year":"2021","journal-title":"Med Res Rev"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12943-018-0775-3","article-title":"Tyrosine kinase inhibitors enhanced the efficacy of conventional chemotherapeutic agent in multidrug resistant cancer cells","volume":"17","author":"Wu","year":"2018","journal-title":"Mol Cancer"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/s11899-021-00638-0","article-title":"Pegaspargase in practice: minimizing toxicity, maximizing benefit","volume":"16","author":"Riley","year":"2021","journal-title":"Current Hematol Malig Rep"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"3496","DOI":"10.1200\/JCO.20.03692","article-title":"Efficacy and toxicity of pegaspargase and calaspargase pegol in childhood acute lymphoblastic leukemia: results of DFCI 11-001","volume":"39","author":"Vrooman","year":"2021","journal-title":"J Clin Oncol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1182\/blood.V99.6.1986","volume":"99","author":"Avramis","year":"2002","journal-title":"Blood"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"8729","DOI":"10.18632\/aging.204355","article-title":"Deep remission from induction chemotherapy predicts favorable long-term survivals in early stage extranodal nasal NK\/T-cell lymphoma receiving sequential chemotherapy and radiation","volume":"14","author":"Qi","year":"2022","journal-title":"Aging"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s40265-019-01120-1","article-title":"Pegaspargase: a review in acute lymphoblastic leukaemia","volume":"79","author":"Heo","year":"2019","journal-title":"Drugs"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"991","DOI":"10.3390\/medicina58080991","article-title":"Pancreas involvement of extranodal natural killer\/T-cell lymphoma, nasal type, presenting as acute pancreatitis: a case report","volume":"58","author":"Lee","year":"2022","journal-title":"Medicina"}],"container-title":["Oncology Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/cdn.techscience.cn\/files\/or\/2025\/TSP_OR-33-4\/OncolRes-33-04-57065\/OncolRes-33-57065.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T06:33:07Z","timestamp":1763101987000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.techscience.com\/or\/v33n4\/60037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":30,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025]]},"published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.32604\/or.2024.057065","relation":{},"ISSN":["1555-3906"],"issn-type":[{"value":"1555-3906","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"2024-08-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-22","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-19","order":2,"name":"published","label":"Published Online","group":{"name":"publication_history","label":"Publication History"}}]}}